3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Small Cell Lung Carcinoma
15
Lung Neoplasms
5
Neoplasms
4
Sarcoma
3
Sarcoma, Ewing
2
Neuroendocrine Tumors
2
Desmoplastic Small Round Cell Tumor
2
Stomach Neoplasms
1
SCLC, Extensive Stage
1
Platinum-Resistant Lung Small Cell Carcinoma
1
Ovarian Neoplasms
1
Neutropenia
1
Mesothelioma
1
Leiomyosarcoma
1
Glioblastoma
1
Gastrointestinal Malignancies
1
Gastro-enteropancreatic neuroendocrine tumor
1
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Small Cell
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Non-Small-Cell Lung
1
Advanced Solid Tumors
1
Advanced Solid Tumor
1
Adenoma, Islet Cell
1
Interventions
sacituzumab govitecan
1
amrubicin
1
Topotecan
1
PM 01183
1
Drug Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
×
PM 01183
×
1 year
×
Clear all
NCT06801834
2026-05-20
EVOKE-SCLC-04
Gilead Sciences
Phase 3
Recruiting
695 enrolled